Back to my company list

New
B

BioSimulytics

The AI engine Fit Assessment

Beta

The company provides pharma-focused in-silico drug development solutions using AI, quantum computing and HPC for pharmaceutical R&D, including crystal-structure prediction and polymorph risk assessment.

Blurb

Developer of an AI-enhanced predictive platform designed to assist pharmaceuticals with the development of drugs. The company's platform uses a combination of molecular chemistry, quantum physics, and artificial intelligence computing for crystal-structure prediction, enabling researchers to predict the stable polymorph, bringing speed, certainty, and product data quality.

HQ Location

Dublin (Ireland)

Founded

2019

Employees

1 - 10

Total funding raised

Not available

Funding Status

Not available

Developer of an AI-enhanced predictive platform designed to assist pharmaceuticals with the development of drugs. The company's platform uses a combination of molecular chemistry, quantum physics, and artificial intelligence computing for crystal-structure prediction, enabling researchers to predict the stable polymorph, bringing speed, certainty, and product data quality.